Biokin Pharma's Commercialization Deal With Bristol Myers Squibb for Cancer Drug Becomes Effective
Biokin Pharma's Commercialization Deal With Bristol Myers Squibb for Cancer Drug Becomes Effective
Biokin Pharma與百時美施貴寶的抗癌藥物商業化協議生效
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊